Business · 1 sources covering this

Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue

The strong performance the company has delivered in Q2 reflected the strength of the business fundamentals, sustained execution and the resilience of its diversified product portfolio.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

The HinduLean L·49m ago
Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue
The strong performance the company has delivered in Q2 reflected the strength of the business fundamentals, sustained execution and the resilience of its diversified product portfolio.
Read at The Hindu →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/ac95379019b788a0511ecc9e0b006c4f340293da"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue"></iframe>

Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue

How 1 sources are covering this

Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue

More from Business

Buying coffee or renting table? Bengaluru cafe owner faces loss due to customers spending ₹150 and overstaying

Karnataka’s Nandini paneer, ghee, curd prices hiked a week after milk: Check your pocket pinch as new rates implemented

Gold prices to lift jewellery revenue 21-23% despite volume dip: Crisil

Bomb threats force emergency landings of multiple flights across Europe

Reader

Trust & legal

Across the network